FDA approves Zohydro ER
Last month the FDA approved a new high-dose narcotic painkiller, Zohydro ER, against the advice of its own advisors. Zohydro ER is five to 10 times stronger than traditional opioid painkillers and does not have abuse-deterrent properties. However, the FDA argues the benefits of Zohydro ER outweigh the costs.....
Source: Sound Medicine - Category: Global & Universal Authors: Sound Medicine Source Type: news
More News: International Medicine & Public Health